Coronary microvascular dysfunction in systemic sclerosis: insights from PET-derived myocardial flow reserve
- 22 April 2026
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (5)
Abstract
Objectives: Cardiovascular death is the second leading cause in systemic sclerosis (SSc), with coronary microvascular dysfunction (CMVD) playing a key role. PET-derived myocardial blood flow (MBF) and flow reserve (MFR) offer a validated, non-invasive way to assess CMVD. We studied the prevalence of impaired MFR in SSc and its association with vasodilator or immunomodulatory therapy. Methods: SSc patients who underwent dynamic 82-Rubidium PET myocardial perfusion imaging (MPI) at Yale New Haven Hospital (July 2016 to April 2025) were studied. Patients were matched 3:1 with controls without autoimmune rheumatologic disease based on age, sex, BMI and cardiovascular comorbidities. Abnormal MFR was defined as <2.0. Results: The cohort included 67 SSc patients (87% female, age: 61 ± 11 years, 21% diffuse cutaneous SSc, SSc duration: 12 ± 10 years) and 201 controls. Rest MBF was higher in SSc (1.14 [IQR 0.91–1.39] ml/g/min) vs controls (1.00 [IQR 0.78–1.25]; P = 0.01), while MFR was lower (2.17 [IQR 1.84–2.57] vs 2.44 [IQR 1.96–2.96]; P = 0.01). Stress MBF was similar (2.47 [IQR 1.99–2.82] vs 2.43 [IQR 1.91–3.04]; P = 0.85). Multivariable analysis showed MMF use linked to lower odds of abnormal MFR (OR 0.09 [95% CI 0.01–0.56]; P = 0.017), while calcium channel blockers (OR 7.77 [1.93–42.53]; P = 0.008) and statins (OR 7.14 [1.86–36.87]; P = 0.008) increased odds. Conclusions: PET MPI reveals reduced MFR in SSc. Treatment associations, including MMF, should be interpreted cautiously given the retrospective design. PET-derived MFR may serve as a non-invasive marker of vascular involvement, warranting prospective validation.Keywords
Funding Information
- National Institutes of Health, National Heart, Lung, and Blood Institute (1K23HL168223-01A1)
- National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin diseases (1R01AR085316-01A1)
This publication has 28 references indexed in Scilit:
- Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosisSeminars in Arthritis and Rheumatism, 2024
- Comparison of the prognostic value between quantification and visual estimation of coronary calcification from attenuation CT in patients undergoing SPECT myocardial perfusion imagingThe International Journal of Cardiovascular Imaging, 2023
- Impaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosisRheumatology International, 2023
- Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular DysfunctionJACC: Cardiovascular Imaging, 2023
- Systemic sclerosisThe Lancet, 2022
- Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory DisordersJACC: Cardiovascular Imaging, 2021
- Coronary Microvascular Dysfunction in Rheumatoid Arthritis Compared to Diabetes Mellitus and Association With All‐Cause MortalityArthritis Care & Research, 2021
- Serial Assessment of Coronary Flow Reserve by Rubidium-82 Positron Emission Tomography Predicts Mortality in Heart Transplant RecipientsJACC: Cardiovascular Imaging, 2020
- Quantification of myocardial blood flow with 82Rb dynamic PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Pathologic observations in systemic sclerosis (scleroderma)The American Journal of Medicine, 1969